Die wichtigsten Arbeiten zu.....
Nevirapin (ViramuneR®)

San Francisco, 18. 2. 2010

#591  Risk of Virological Failure of Antiretroviral Regimens Including Nevirapine, Tenofovir, and Emtricitabine (or Lamivudine) in Previously Treated HIV-1 Infected Patients

Josep Llibre*1, J Santos1, R Martin-Iguacel2, I Bravo1, C Caum1,3, N Perez-Alvarez1,3, and B Clotet1,4

1Fndn Lluita contra la SIDA, Hosp Germans Trias i Pujol, Badalona, Spain; 2Aarhus Univ Hosp, Aalborg, Denmark; 3Tech Univ of Catalonia, Barcelona, Spain; and 4Fndn irsiCaixa, Badalona, Spain

#153LB Efficacy of ART with NVP+TDF/FTC vs LPV/r+TDF/FTC among Antiretroviral-naïve Women in Africa: OCTANE Trial 2/ACTG A5208

James McIntyre*1, M Hughes2, J Mellors3, Y Zheng2, J Hakim4, A Asmelash5, F Conradie6, R Schooley7, J Currier8, S Lockman2,5,9, and A5208/OCTANE Study Team

1Chris Hani Baragwanath Hosp, Johannesburg, South Africa; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Univ of Pittsburgh Med Ctr, PA, US; 4Univ of Zimbabwe, Harare; 5Botswana-Harvard AIDS Inst, Gaborone; 6Univ of the Witwatersrand, Johannesburg, South Africa; 7Univ of California, San Diego, US; 8Univ of California, Los Angeles, US; and 9Brigham and Women`s Hosp, Boston, MA, US

#154 NNRTI-resistant Variants Detected by Allele-specific PCR Predict Outcome of NVP-containing ART in Women with Prior Exposure to sdNVP: Results from the OCTANE/A5208 Study

Valerie Boltz*1, Y Zheng2, S Lockman3, F Hong4, E Halvas4, J McIntyre5, J Currier6, M Hughes2, J Coffin7, J Mellors4, and A5208 OCTANE Study Team

1HIV Drug Resistance Prgm, NCI-Frederick, MD, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Brigham and Women’s Hosp, Boston, MA, US; 4Univ of Pittsburgh, PA, US; 5Univ of the Witwatersrand, Johannesburg, South Africa; 6Univ of California, Los Angeles, US; and 7Tufts Univ, Boston, MA, US

#430 Correlates of Time-to-Loss-of-Viral-Response in CSF and Plasma in the CHARTER Cohort

Scott Letendre*1, R Ellis1, R Deutsch1, D Clifford2, C Marra3, A McCutchan1, S Morgello4, D Simpson4, R Heaton1, I Grant1, and the CHARTER Group

1Univ of California, San Diego, US; 2Washington Univ in St Louis, MO, US; 3Univ of Washington, Seattle, US; and 4Mt Sinai Sch of Med, New York, NY, US

Meldungen

Ältere Meldungen weiter

Diese Website bietet aktuelle Informationen zu HIV/Aids sowie zur HIV/HCV-Koinfektion. Im Mittelpunkt stehen HIV-Test, Symptome und Auswirkungen der HIV-Infektion, Behandlung der HIV-Infektion, HIV-Medikamente mit Nebenwirkungen und Komplikationen, Aids, Hepatitis B und C. Ein Verzeichnis der Ärzte mit Schwerpunkt HIV ergänzt das Angebot.